Reserve Bank of India allowed Startups with an overseas subsidiary to open foreign currency accounts to credit to the account foreign exchange earnings from exports and sales made by the startup or its subsidiary.

On February 03, 2020, the Ministry of Health and Family Welfare, Government of India, put forth a proposal to amend the Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954...

The Ministry of Health & Family Welfare has recently announced the launch of daily regimen for TB patients across the country, under the Revised National TB Control Programme (RNTCP).

The applicant may group medical devices having same or similar intended uses or commonality of technology and submitted in a single application.

On March 19, 2020, the Central Drug Standard Control Organization has published a notice regarding the regulatory pathway for R&D of IVD kit for diagnosis of COVID-19 in order to...

IBBI issued a circular on 17 October, 2018 directing that with effect from 1 February, 2019, no Insolvency Professional shall appoint a person other than a Registered Valuer to conduct any valuation under the Code or any of the regulations made thereunder.

What's the difference between a ‘brand' and a ‘strong brand name'? … The value of a brand is built over time by continuous investments in marketing, research and development, constant product...

The Indian patent office has recently launched a new numbering system for all the Patent application filed in India and the Request for Examination.

Though IPAIRS allows a search conducted in all the Indian Patents and Patent Applications, the system however does not allow a user to perform a full-text search.

This article looks into the challenges faced in the patenting of therapeutic antibodies in India.

It takes at least ten years for a new medicine to complete its journey from initial discovery to marketplace in treating patients.

This is an alert with respect to recent Publication and Notification of Patent (Amendment) Rules, 2014 by the Government of India.

Pfizer Products, Inc. (Pfizer) filed Indian patent application 991/MUMNP/2003 entitled "Chiral Salt Resolution" in the Indian Patent Office (IPO) on October 27, 2003.

In effect, the Supreme Court held that a prior application for registration of a mark is of no assistance if the use of the said mark is commenced after twelve years that too after the rival's use of their mark.

Recently the IPO has issued the new computer related guidelines (CRI) for examine the Patent application in India.

The Office of the Controller General of Patents, Designs and Trademarks (CGPDTM) issued new Guidelines on Examination of Computer Related Inventions (CRIs) on 30th June, 2017 replacing the earlier published...

The Office of the Controller General of Patents, Designs and Trademarks (CGPDTM) issued new Guidelines on Examination of Computer Related Inventions (CRIs) on 30th June, 2017 replacing the earlier published Guidelines in February 2016.

The Office of the Comptroller General of Patents Designs and Trademarks on 22nd April, 2016 has finally released the Scheme for Facilitating Start-Ups Intellectual Property Protection (SIPP).

Section 244A of the Income-tax Act provides that if any amount of refund becomes due to the assessee under the income-tax Act, he shall, subject to the provisions of this section, be entitled to receive...

The availability of new drugs and biological products often means new treatment options for patients and advances in health care.